Clinical Trial Update: Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating radiation therapy in combination with durvalumab for pancreatic adenocarcinoma; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Durvalumab (durvalumab)
• Radiation therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING